Co-morbidities

ESC 24: MRAs in Heart Failure

Watch time: 5m 46s

Biykem Bozkurt, Muthiah Vaduganathan, , et al

Watch time: 1h 1m 12s
HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Harriette Van Spall, Mark Petrie

Watch time: 15m 26s

Harriette Van Spall, Mark Petrie

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer

Watch time: 1h 5m 20s
CardioNerds @AHA23: An Extended Duration Short-Interfering RNA Targeting Lp(a)

Steven E Nissen, Maryam Barkhordarian

Watch time: 9m 14s
AHA 23 Late-Breaker Discussion: The DAPA-MI Trial

Harriette Van Spall, Stefan James

Watch time: 14m 14s
2023 ESC Guidelines Update: Acute & Chronic Heart Failure

Giuseppe Rosano, Harriette Van Spall

Watch time: 10m 8s
HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s
HFA 23: DAPA-HF and DELIVER: KCCQ in Pts with Varying Ejection Fraction

Ankeet Bhatt

Watch time: 4m 45s
HFA 23: DAPA-RESIST: Dapagliflozin Vs Metolazone in Diuretic-Resistant HF

Ross Campbell

Watch time: 3m 56s

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 4m (6 videos)

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)

Muthiah Vaduganathan

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Andrew JS Coats, Stefan Anker

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Watch time: 53m 14s (5 videos)
The PRESERVED-HF Study – Main Study Presentation and Peer-to-peer Discussion

Mikhail Kosiborod, Dalane W Kitzman

Watch time: 36m 12s (5 videos)

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall

Watch time: 5m 48s

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Shelley Zieroth

Watch time: 3m 59s (1 video)
Radcliffe & CardioNerds @AHA22: IRONMAN: Intravenous Ferric Derisomaltose in HF With Reduced EF

Rawan Amir, Paul Kalra

Watch time: 18m 58s

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Paul Kalra

Watch time: 12m 41s (2 videos)

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 4m (6 videos)

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s

Media

Biykem Bozkurt, Muthiah Vaduganathan, , et al

Watch time: 1h 1m 12s

Andrew JS Coats, Stefan Anker

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Muthiah Vaduganathan

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s
ESC 22: EMPEROR-POOLED: Clinical Benefits of SGLT2i in Heart Failure

Faiez Zannad

Watch time: 4m 44s

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)
ESC 22: EMPEROR-Preserved & DELIVER Meta-Analysis: SGLT2is in HF

Muthiah Vaduganathan

Watch time: 5m 1s
AHA 22: Efficacy of Empagliflozin in Black vs White Pts With Heart Failure

Subodh Verma

Watch time: 5m

Shelley Zieroth

Watch time: 3m 59s (1 video)

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Articles

COVID-19 Pandemic and Cardiovascular Disease

Aniket S Rali

,

Andrew J Sauer

,

Published:

25 March 2020

Citation:

US Cardiology Review 2020;14:e01.

DOI:

https://doi.org/10.15420/usc.2020.14
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1396
  • Downloads: Downloads 31
  • Citations: 10
  • Read time: 15m

Impact of Atrial Septal Defect on Hemodynamics

Saumil R Shah

,

Sergio Waxman

,

William H Gaasch

,

Citation:

US Cardiology Review 2017;11(2):72–4.

DOI:

https://doi.org/10.15420/ucs.2017:9:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5271
  • Downloads: Downloads 31
  • Citations: 4

Transvenous Phrenic Nerve Stimulation - A Novel Therapy for Central Sleep Apnea in Heart Failure

Sitaramesh Emani

,

William T Abraham

,

Citation:

US Cardiology 2012;9(1):53-6

DOI:

https://doi.org/10.15420/usc.2012.9.1.53
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1091
  • Downloads: Downloads 3
  • Citations: 1

Central Sleep Apnea in Heart Failure

Rami Khayat

,

Andrew Pederzoli

,

William T Abraham

,

Citation:

US Cardiology 2009;6(2):72–8

DOI:

https://doi.org/10.15420/usc.2009.6.2.72
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 6537
  • Downloads: Downloads 12
  • Citations: 5